Oncology ASCO 2023 – Jaydev Thakkar In our penultimate video from ASCO 2023, editor-in-chief Jonah Comstock touches base with Biofourmis chief operating officer Jaydev Thakkar.
Digital Short-term crucial to future of AI drug discovery One of the lead prospects in a new generation of AI-developed drug candidates struggled in late-stage trials.
R&D New strategies to manage clinical trial risk It is essential for healthcare and pharmaceutical companies to be aware of both critical and non-critical risks when conducting quality clinical trials.
Sales & Marketing Delivering for the 5 in 10,000 patients with a rare disease An estimated 30 million people are living with a rare disease in the European Union alone.
Digital The digital skills pharma leaders need in 2023 Pharma companies are needing to look at cost-effective ways to stay ahead of the competition.
Digital The power of a carer's intuition - AI in social care Data and AI allow carers to better understand which patients are at risk and intervene earlier.
News FDA points to liver injury with Amgen's Tavneos The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
